WCN'26 Industry Symposia

Register
- Non-member - Free!
- Member - Free!
- Subscriber - Free!
- Free trial - Free!
Continue

Overview
Content

WCN'26 Industry Symposia

WCN'26: Industry Spotlight Session: Atypical hemolytic uremic syndrome (aHUS) in focus
- More Information
WCN'26: Industry Symposium 59: Beyond the kidneys: The importance of early intervention and managing cardiovascular risk in patients with CKD
- More Information
WCN'26: Industry Symposium 57: New Trends in Lupus Nephritis
- More Information
WCN'26: Industry Symposium 56: The significance of potassium management in CKD treatment
- More Information
WCN'26: Industry Symposium 48: Combination with Confidence: Finerenone for Kidney and Heart Protection
- More Information
WCN'26: Industry Symposium 47: KDIGO IgAN Session
- More Information
WCN'26: Industry Symposium 44: The evolving IgAN treatment paradigm- Why target the gut?
- More Information
WCN'26: Industry Symposium 43: Reimagining Anemia Management in CKD: Evolution with HIF-PHIs
- More Information
WCN'26: Industry Symposium 36: Emerging Therapies in IgA Nephropathy: Innovations in B-Cell Modulation and Dual BAFF/APRIL Inhibition
- More Information
WCN'26: Industry Symposium 34: New horizons in C3G and primary IC-MPGN: navigating the future of patient care
- More Information

«
1
2
3
»